Stoke Therapeutics, Inc. (STOK)
NASDAQ: STOK · IEX Real-Time Price · USD
12.83
-1.04 (-7.50%)
At close: Jul 2, 2024, 4:00 PM
13.47
+0.64 (4.99%)
After-hours: Jul 2, 2024, 5:09 PM EDT
Stoke Therapeutics Market Cap
Stoke Therapeutics has a market cap or net worth of $668.71 million as of July 2, 2024. Its market cap has increased by 45.02% in one year.
Market Cap
668.71M
Enterprise Value
489.56M
1-Year Change
45.02%
Ranking
Category
Stock Price
$12.83
Market Cap Chart
Since June 19, 2019, Stoke Therapeutics's market cap has decreased from $774.00M to $668.71M, a decrease of -13.60%. That is a compound annual growth rate of -2.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2024 | 668.70M | 184.67% |
| Dec 29, 2023 | 234.90M | -35.45% |
| Dec 30, 2022 | 363.90M | -58.77% |
| Dec 31, 2021 | 882.60M | -57.42% |
| Dec 31, 2020 | 2.07B | 123.63% |
| Dec 31, 2019 | 926.90M | 19.75% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CureVac | 746.94M |
| Harrow Health | 744.79M |
| Cytek Biosciences | 736.44M |
| CARGO Therapeutics | 733.79M |
| Immunome | 731.62M |
| HilleVax | 716.98M |
| Ginkgo Bioworks Holdings | 714.69M |
| ProKidney | 713.55M |